UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer

The New England journal of medicine, 2022-03, Vol.386 (12), p.1132-1142

2022

Link zum Volltext

Verfügbarkeit prüfen

Dynamic modeling of a radially multilayered tether cable for a remotely-operated underwater vehicle (ROV) based on the absolute nodal coordinate formulation (ANCF)

Mechanism and machine theory, 2020-11, Vol.153, p.103961, Article 103961

2020

Link zum Volltext

Verfügbarkeit prüfen

OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor‐positive breast carcinoma

Cancer science, 2018-10, Vol.109 (10), p.3350-3359

2018

Link zum Volltext

Verfügbarkeit prüfen

Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study

Brain (London, England : 1878), 2020-05, Vol.143 (5), p.1431-1446

2020

Link zum Volltext

Verfügbarkeit prüfen

Experimental and numerical study on the high-speed ship hydrodynamics influenced by an interceptor with varied angle of attack

International Journal of Naval Architecture and Ocean Engineering, 2024, 15(0), , pp.1-15

2024

Link zum Volltext

Verfügbarkeit prüfen

Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders

Brain (London, England : 1878), 2021-09, Vol.144 (8), p.2401-2415

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma

Surgery, 2016-03, Vol.159 (3), p.763-770

2016

Link zum Volltext

Verfügbarkeit prüfen

Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker

Future oncology (London, England), 2018-10, Vol.14 (24), p.2543

2018

Link zum Volltext

Verfügbarkeit prüfen

Carbon‐ion radiotherapy for urological cancers

International journal of urology, 2022-10, Vol.29 (10), p.1109-1119

2022

Link zum Volltext

Verfügbarkeit prüfen

Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy

Neurologia medico-chirurgica, 2020, Vol.60(1), pp.37-44

2020

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial

Japanese journal of clinical oncology, 2016-02, Vol.46 (2), p.152-162

2016

Link zum Volltext

Verfügbarkeit prüfen

Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas

Brain tumor pathology, 2015-04, Vol.32 (2), p.99-104

2015

Link zum Volltext

Verfügbarkeit prüfen

Apalutamide for metastatic, castration‐sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double‐blind, placebo‐controlled phase 3 TITAN study

International journal of urology, 2021-03, Vol.28 (3), p.280-287

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk assessment of multi-factorial complications after transrectal ultrasound-guided prostate biopsy: a single institutional retrospective cohort study

International journal of clinical oncology, 2021-12, Vol.26 (12), p.2295-2302

2021

Link zum Volltext

Verfügbarkeit prüfen

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Acta neuropathologica communications, 2016-08, Vol.4 (1), p.79, Article 79

2016

Link zum Volltext

Verfügbarkeit prüfen

A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG 2a -f) Exerts Antitumor Activity in a Mouse Xenograft Model of Renal Cell Cancers

Monoclonal antibodies in immunodiagnosis and immunotherapy, 2022-12, Vol.41 (6), p.320

2022

Link zum Volltext

Verfügbarkeit prüfen

External validation of the Candiolo nomogram for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy: a retrospective cohort study

Japanese journal of clinical oncology, 2022-08, Vol.52 (8), p.950-953

2022

Link zum Volltext

Verfügbarkeit prüfen

Carbon Ion Radiotherapy in Advanced Hypofractionated Regimens for Prostate Cancer: From 20 to 16 Fractions

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (4), p.968-972

2012

Link zum Volltext

Verfügbarkeit prüfen

Inflammation and PD-L1 expression in pulmonary neuroendocrine tumors

Endocrine-related cancer, 2018-03, Vol.25 (3), p.339-350

2018

Link zum Volltext

Verfügbarkeit prüfen

Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease

Japanese journal of clinical oncology, 2021-08, Vol.51 (8), p.1287-1297

2021

Link zum Volltext

Verfügbarkeit prüfen

Editorial Comment to Changes in quality of life after laparoscopic adrenalectomy for patients with primary aldosteronism: Prospective 2‐year longitudinal cohort study in a Japanese tertiary center

International journal of urology, 2019-07, Vol.26 (7), p.753-754

2019

Link zum Volltext

Verfügbarkeit prüfen

Hemorrhage owing to cerebral cavernous malformation: imaging, clinical, and histopathological considerations

Japanese journal of radiology, 2020-07, Vol.38 (7), p.613-621

2020

Link zum Volltext

Verfügbarkeit prüfen

Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations

Brain tumor pathology, 2018-01, Vol.35 (1), p.10-18

2018

Link zum Volltext

Verfügbarkeit prüfen

Cancer‐specific mortality of high‐risk prostate cancer after carbon‐ion radiotherapy plus long‐term androgen deprivation therapy

Cancer science, 2017-12, Vol.108 (12), p.2422-2429

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study

Japanese journal of clinical oncology, 2020-07, Vol.50 (7), p.810-820

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.369

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(980)
Mit Volltextzugriff
(1.229)

Publikationsform

Sprache

Englisch
(1.157)
Japanisch
(605)
Koreanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer

Dynamic modeling of a radially multilayered tether cable for a remotely-operated underwater vehicle (ROV) based on the absolute nodal coordinate formulation (ANCF)

OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor‐positive breast carcinoma

Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study

Experimental and numerical study on the high-speed ship hydrodynamics influenced by an interceptor with varied angle of attack

Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders

Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma

Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker

Carbon‐ion radiotherapy for urological cancers

Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy

Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial

Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas

Apalutamide for metastatic, castration‐sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double‐blind, placebo‐controlled phase 3 TITAN study

Risk assessment of multi-factorial complications after transrectal ultrasound-guided prostate biopsy: a single institutional retrospective cohort study

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG 2a -f) Exerts Antitumor Activity in a Mouse Xenograft Model of Renal Cell Cancers

External validation of the Candiolo nomogram for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy: a retrospective cohort study

Carbon Ion Radiotherapy in Advanced Hypofractionated Regimens for Prostate Cancer: From 20 to 16 Fractions

Inflammation and PD-L1 expression in pulmonary neuroendocrine tumors

Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease

Editorial Comment to Changes in quality of life after laparoscopic adrenalectomy for patients with primary aldosteronism: Prospective 2‐year longitudinal cohort study in a Japanese tertiary center

Hemorrhage owing to cerebral cavernous malformation: imaging, clinical, and histopathological considerations

Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations

Cancer‐specific mortality of high‐risk prostate cancer after carbon‐ion radiotherapy plus long‐term androgen deprivation therapy

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study

Suchergebnisse filtern